Anti-monocyte chemoattractant protein-1 gene therapy attenuates renal injury induced by protein-overload proteinuria

Hideaki Shimizu, Shoichi Maruyama, Yukio Yuzawa, Tomomi Kato, Yusuke Miki, Satoshi Suzuki, Waichi Sato, Yoshiki Morita, Hiroki Maruyama, Kensuke Egashira, Seiichi Matsuo

Research output: Contribution to journalArticle

112 Citations (Scopus)

Abstract

It has been postulated that protein filtered through glomeruli activates tubular epithelial cells, which secrete vasoactive and inflammatory substances including chemokines, leading to tubulointerstitial renal injury. The present study was designed to investigate the role of monocyte chemoattractant protein-1 (MCP-1) in this process and to evaluate the effectiveness of a kidney-targeted gene transfer technique using hydrodynamic pressure. Naked plasmid encoding 7ND (an MCP-1 antagonist) or a control plasmid was introduced into the left kidney of rats. Three days after gene transfer (day 0), intraperitoneal administration of bovine serum albumin (10 mg/g body wt per day) was started and continued for 14 or 21 d. RT-PCR showed that 7ND mRNA was expressed only in the gene-transfected kidney. Immunostaining showed that 7ND protein was localized in the interstitial cells. Macrophage infiltration was significantly reduced in the left kidney of rats treated with 7ND on days 14 and 21. In the right kidney, such effects were not observed. 7ND also attenuated tubular damage and decreased the number of apoptotic cells. Computer-assisted analysis revealed that the areas positively stained for α-smooth muscle actin (αSMA), fibronectin-EDA, type I collagen, and collagen fibrils were significantly reduced in the 7ND-treated kidney on day 21. Furthermore, 7ND gene therapy significantly reduced MCP-1 and TGF-β1 mRNA expression. These results demonstrate that MCP-1 plays an important role in the development of tubulointerstitial inflammation, tubular damage, and fibrosis induced by proteinuria. The fact that 7ND gene therapy had little effect on the contralateral kidney indicates that 7ND acted locally. This strategy may have a potential usefulness as a gene therapy against tubulointerstitial renal injury.

Original languageEnglish
Pages (from-to)1496-1505
Number of pages10
JournalJournal of the American Society of Nephrology
Volume14
Issue number6
DOIs
Publication statusPublished - 01-06-2003
Externally publishedYes

Fingerprint

Chemokine CCL2
Proteinuria
Genetic Therapy
Kidney
Wounds and Injuries
Proteins
Plasmids
Gene Transfer Techniques
Messenger RNA
Hydrodynamics
Bovine Serum Albumin
Collagen Type I
Fibronectins
Chemokines
Genes
Smooth Muscle
Actins
Fibrosis
Collagen
Cell Count

All Science Journal Classification (ASJC) codes

  • Nephrology

Cite this

Shimizu, Hideaki ; Maruyama, Shoichi ; Yuzawa, Yukio ; Kato, Tomomi ; Miki, Yusuke ; Suzuki, Satoshi ; Sato, Waichi ; Morita, Yoshiki ; Maruyama, Hiroki ; Egashira, Kensuke ; Matsuo, Seiichi. / Anti-monocyte chemoattractant protein-1 gene therapy attenuates renal injury induced by protein-overload proteinuria. In: Journal of the American Society of Nephrology. 2003 ; Vol. 14, No. 6. pp. 1496-1505.
@article{4548bc3ba94e4a2faf5c62f5b47f2f5b,
title = "Anti-monocyte chemoattractant protein-1 gene therapy attenuates renal injury induced by protein-overload proteinuria",
abstract = "It has been postulated that protein filtered through glomeruli activates tubular epithelial cells, which secrete vasoactive and inflammatory substances including chemokines, leading to tubulointerstitial renal injury. The present study was designed to investigate the role of monocyte chemoattractant protein-1 (MCP-1) in this process and to evaluate the effectiveness of a kidney-targeted gene transfer technique using hydrodynamic pressure. Naked plasmid encoding 7ND (an MCP-1 antagonist) or a control plasmid was introduced into the left kidney of rats. Three days after gene transfer (day 0), intraperitoneal administration of bovine serum albumin (10 mg/g body wt per day) was started and continued for 14 or 21 d. RT-PCR showed that 7ND mRNA was expressed only in the gene-transfected kidney. Immunostaining showed that 7ND protein was localized in the interstitial cells. Macrophage infiltration was significantly reduced in the left kidney of rats treated with 7ND on days 14 and 21. In the right kidney, such effects were not observed. 7ND also attenuated tubular damage and decreased the number of apoptotic cells. Computer-assisted analysis revealed that the areas positively stained for α-smooth muscle actin (αSMA), fibronectin-EDA, type I collagen, and collagen fibrils were significantly reduced in the 7ND-treated kidney on day 21. Furthermore, 7ND gene therapy significantly reduced MCP-1 and TGF-β1 mRNA expression. These results demonstrate that MCP-1 plays an important role in the development of tubulointerstitial inflammation, tubular damage, and fibrosis induced by proteinuria. The fact that 7ND gene therapy had little effect on the contralateral kidney indicates that 7ND acted locally. This strategy may have a potential usefulness as a gene therapy against tubulointerstitial renal injury.",
author = "Hideaki Shimizu and Shoichi Maruyama and Yukio Yuzawa and Tomomi Kato and Yusuke Miki and Satoshi Suzuki and Waichi Sato and Yoshiki Morita and Hiroki Maruyama and Kensuke Egashira and Seiichi Matsuo",
year = "2003",
month = "6",
day = "1",
doi = "10.1097/01.ASN.0000069223.98703.8E",
language = "English",
volume = "14",
pages = "1496--1505",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "6",

}

Shimizu, H, Maruyama, S, Yuzawa, Y, Kato, T, Miki, Y, Suzuki, S, Sato, W, Morita, Y, Maruyama, H, Egashira, K & Matsuo, S 2003, 'Anti-monocyte chemoattractant protein-1 gene therapy attenuates renal injury induced by protein-overload proteinuria', Journal of the American Society of Nephrology, vol. 14, no. 6, pp. 1496-1505. https://doi.org/10.1097/01.ASN.0000069223.98703.8E

Anti-monocyte chemoattractant protein-1 gene therapy attenuates renal injury induced by protein-overload proteinuria. / Shimizu, Hideaki; Maruyama, Shoichi; Yuzawa, Yukio; Kato, Tomomi; Miki, Yusuke; Suzuki, Satoshi; Sato, Waichi; Morita, Yoshiki; Maruyama, Hiroki; Egashira, Kensuke; Matsuo, Seiichi.

In: Journal of the American Society of Nephrology, Vol. 14, No. 6, 01.06.2003, p. 1496-1505.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Anti-monocyte chemoattractant protein-1 gene therapy attenuates renal injury induced by protein-overload proteinuria

AU - Shimizu, Hideaki

AU - Maruyama, Shoichi

AU - Yuzawa, Yukio

AU - Kato, Tomomi

AU - Miki, Yusuke

AU - Suzuki, Satoshi

AU - Sato, Waichi

AU - Morita, Yoshiki

AU - Maruyama, Hiroki

AU - Egashira, Kensuke

AU - Matsuo, Seiichi

PY - 2003/6/1

Y1 - 2003/6/1

N2 - It has been postulated that protein filtered through glomeruli activates tubular epithelial cells, which secrete vasoactive and inflammatory substances including chemokines, leading to tubulointerstitial renal injury. The present study was designed to investigate the role of monocyte chemoattractant protein-1 (MCP-1) in this process and to evaluate the effectiveness of a kidney-targeted gene transfer technique using hydrodynamic pressure. Naked plasmid encoding 7ND (an MCP-1 antagonist) or a control plasmid was introduced into the left kidney of rats. Three days after gene transfer (day 0), intraperitoneal administration of bovine serum albumin (10 mg/g body wt per day) was started and continued for 14 or 21 d. RT-PCR showed that 7ND mRNA was expressed only in the gene-transfected kidney. Immunostaining showed that 7ND protein was localized in the interstitial cells. Macrophage infiltration was significantly reduced in the left kidney of rats treated with 7ND on days 14 and 21. In the right kidney, such effects were not observed. 7ND also attenuated tubular damage and decreased the number of apoptotic cells. Computer-assisted analysis revealed that the areas positively stained for α-smooth muscle actin (αSMA), fibronectin-EDA, type I collagen, and collagen fibrils were significantly reduced in the 7ND-treated kidney on day 21. Furthermore, 7ND gene therapy significantly reduced MCP-1 and TGF-β1 mRNA expression. These results demonstrate that MCP-1 plays an important role in the development of tubulointerstitial inflammation, tubular damage, and fibrosis induced by proteinuria. The fact that 7ND gene therapy had little effect on the contralateral kidney indicates that 7ND acted locally. This strategy may have a potential usefulness as a gene therapy against tubulointerstitial renal injury.

AB - It has been postulated that protein filtered through glomeruli activates tubular epithelial cells, which secrete vasoactive and inflammatory substances including chemokines, leading to tubulointerstitial renal injury. The present study was designed to investigate the role of monocyte chemoattractant protein-1 (MCP-1) in this process and to evaluate the effectiveness of a kidney-targeted gene transfer technique using hydrodynamic pressure. Naked plasmid encoding 7ND (an MCP-1 antagonist) or a control plasmid was introduced into the left kidney of rats. Three days after gene transfer (day 0), intraperitoneal administration of bovine serum albumin (10 mg/g body wt per day) was started and continued for 14 or 21 d. RT-PCR showed that 7ND mRNA was expressed only in the gene-transfected kidney. Immunostaining showed that 7ND protein was localized in the interstitial cells. Macrophage infiltration was significantly reduced in the left kidney of rats treated with 7ND on days 14 and 21. In the right kidney, such effects were not observed. 7ND also attenuated tubular damage and decreased the number of apoptotic cells. Computer-assisted analysis revealed that the areas positively stained for α-smooth muscle actin (αSMA), fibronectin-EDA, type I collagen, and collagen fibrils were significantly reduced in the 7ND-treated kidney on day 21. Furthermore, 7ND gene therapy significantly reduced MCP-1 and TGF-β1 mRNA expression. These results demonstrate that MCP-1 plays an important role in the development of tubulointerstitial inflammation, tubular damage, and fibrosis induced by proteinuria. The fact that 7ND gene therapy had little effect on the contralateral kidney indicates that 7ND acted locally. This strategy may have a potential usefulness as a gene therapy against tubulointerstitial renal injury.

UR - http://www.scopus.com/inward/record.url?scp=0038512466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038512466&partnerID=8YFLogxK

U2 - 10.1097/01.ASN.0000069223.98703.8E

DO - 10.1097/01.ASN.0000069223.98703.8E

M3 - Article

VL - 14

SP - 1496

EP - 1505

JO - Journal of the American Society of Nephrology : JASN

JF - Journal of the American Society of Nephrology : JASN

SN - 1046-6673

IS - 6

ER -